GEN Exclusives

More »

GEN News Highlights

More »
Jul 22, 2014

Novel Methods May Help Stem Cells Survive Transplantation into Damaged Tissues

  • Stem cells offer much promise for treating damaged organs and tissues, but with current transplantation approaches stem cell survival is poor, limiting their effectiveness. New methods are being developed and tested to improve the survival and optimize their therapeutic function after transplantation, as described in a Review article in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

    In the article "Preconditioning Stem Cells for In Vivo Delivery," Sébastien Sart from Ecole Polytechnique and Teng Ma and Yan Li from Florida State University examine the leading strategies for preconditioning stem cells prior to transplantation to prepare them for the environment often found in damaged tissue. Preconditioning methods might include exposing stem cells to microenvironments characterized by reduced oxygen levels, heat shock, and oxidative stress, creating three-dimensional stem cell aggregates or microtissues, and using hydrogels in which to embed or encapsulate the cells.

    “This article provides an extensive review of the current methods of stem cell preconditioning for transplantation,” says BioResearch Open Access editor Jane Taylor, Ph.D., MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. “It also highlights the cutting-edge technologies employed to do this.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?